Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02458690 · ClinicalTrials.gov registry record · Phase 2
eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients
A Phase 2 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 2
- Development phase
- 216
- Enrollment target
NCT02458690 is a Phase 2 study that has completed, run by Indiana University. The registered enrollment target is 216 participants.
The verdict
NCT02458690, a Phase 2 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 216 participants
- Enrollment target
Study Summary
The objective of this randomized controlled trial is to evaluate whether the investigators modernized IMPACT intervention for depression (eIMPACT), delivered before the onset of cardiovascular disease (CVD), reduces the risk of future CVD. Participants will be primary care patients who are depressed but do not have a history of CVD. Half of the participants will receive standard depression treatment in primary care (usual care), and the other half will receive one year of eIMPACT, a collaborative stepped care program including antidepressants and computerized and telephonic cognitive-behavioral therapy. To evaluate change in CVD risk, the investigators will measure artery function using ultrasound before and after the 1-year treatment period. It is hypothesized that patients who receive the eIMPACT intervention will have greater improvements in artery function than patients who receive usual care.
Interventions
- OTHER Usual Care
- BEHAVIORAL Beating the Blues (BtB)
- BEHAVIORAL Problem Solving Treatment in Primary Care (PST-PC)
- DRUG Antidepressant Medications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2015-07 |
| Est. Completion | 2021-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02458690
The ClinicalTrials.gov registry entry for NCT02458690 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 216 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Usual Care is the first listed.
NCT02458690 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02458690 about?
NCT02458690 is a clinical study titled "eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients". The objective of this randomized controlled trial is to evaluate whether the investigators modernized IMPACT intervention for depression (eIMPACT), delivered before the onset of cardiovascular disease (CVD), reduces the risk of future CVD. Participants will be primary care patients who are depressed...
What is the current status of trial NCT02458690?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 216 participants. The study started on 2015-07. Estimated completion is 2021-03.
What interventions are being tested in trial NCT02458690?
The interventions under investigation include: Usual Care (OTHER), Beating the Blues (BtB) (BEHAVIORAL), Problem Solving Treatment in Primary Care (PST-PC) (BEHAVIORAL), Antidepressant Medications (DRUG).
Who is sponsoring clinical trial NCT02458690?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.